Kazia Therapeutics Limited

(NVGNF)

By |

Profile

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others.

Contact Information

Website: www.kaziatherapeutics.com
Email: investment.consultant@novogen.com
Main Phone: +61 294724101
Address: 300 Barangaroo Avenue
Address 2: Level 24
State: NSW
City / Town: Sydney
Country: AU
Postal Code: 2000

Issuer Information

Exchange: GREY
CEO: James Garner
Employees: 5

Equities News

Profile

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others.

Contact Information

Website: www.kaziatherapeutics.com
Email: investment.consultant@novogen.com
Main Phone: +61 294724101
Address: 300 Barangaroo Avenue
Address 2: Level 24
State: NSW
City / Town: Sydney
Country: AU
Postal Code: 2000

Issuer Information

Exchange: GREY
CEO: James Garner
Employees: 5

Equities News

$ 0.20 $ 0. (0.00%)
Last Price 0.20 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 0.20
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap 18.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 126,166,264.00 EPS (TTM) N/A PE Ratio N/A Exchange Greys